NCT04727307
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04727307
Title Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial (AB-LATE02)
Acronym AB-LATE02
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Montpellier
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Amiens Amiens France Details
CHU d'Angers Angers France Details
Hôpital Jean Verdier Bondy France Details
Hôpital Beaujon Clichy France Details
Centre Georges François Leclerc Dijon France Details
CHU Dijon Dijon France Details
CHU de Grenoble Grenoble France Details
CHU de Lille Lille France Details
Hôpital Saint Joseph Marseille France Details
CHU de Montpellier Montpellier France Details
CHRU de Nancy Nancy France Details
CHU de Nantes Nantes France Details
CHU de Nice Nice France Details
CHU Nîmes Nîmes France Details
Hôpital Cochin Paris France Details
CH Perpignan Perpignan France Details
CHU de Poitiers Poitiers France Details
CHU de Rennes Rennes France Details
Institut Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field